Bhutani M S, Barde C J, Markert R J, Gopalswamy N
Center for Endoscopic Ultrasound, University of Texas Medical Branch, Galveston, Texas 77555-0764, USA.
Endoscopy. 2002 Jun;34(6):461-3. doi: 10.1055/s-2002-31996.
Endoscopic ultrasonography (EUS) is considered to be the most accurate modality for T staging of esophageal cancer. This study attempted to determine whether endoscopic features such as the length and degree of luminal stenosis in esophageal cancer can predict the T stage on EUS.
Thirty-five patients with newly diagnosed esophageal adenocarcinoma or squamous-cell carcinoma undergoing EUS prior to initiation of any treatment were included in the study. The length of the tumor was assessed prospectively during esophagogastroduodenoscopy (EGD) before EUS in 22 patients. Radial EUS was then performed in these patients. The other 13 patients had sufficient luminal stenosis to prevent complete advancement of the echo endoscope through the tumor. In these 13 patients, the length of the esophageal cancer was not examined, but the T and N stage up to the level of maximum advancement of the echo endoscope through the tumor were noted.
All 13 patients with luminal stenosis had at least a T3 (n = 12) or T4 (n = 1) lesion up to the level of maximum advancement of the echo endoscope. Among the 22 patients in whom the length of the esophageal cancer was measured, the mean length in the 13 patients with a T1 or T2 lesion on EUS was 2.6 cm. The mean length in the nine patients with T3 esophageal cancer was 7.1 cm. The difference in the mean length of T1 or T2 lesions (2.6 cm) was significantly different ( P < 0.001) from the mean length of T3 lesions (7.1 cm). Using a clinical diagnostic testing approach, when > or = 5 cm length was used as a criteria for diagnosing T3 lesions, the sensitivity was 89 %, specificity 92 %, positive predictive value 89 %, and negative predictive value 92 %. There was also a suggestion of increased chances of lymph-node metastases with increasing length of esophageal cancer.
In esophageal carcinoma, endoscopic features such as the length of the cancer and the degree of luminal stenosis correlate with T staging on EUS. Esophageal cancers that are > or = 5 cm in length, or are sufficiently stenotic to prevent passage of an endoscope, are much more likely to be T3 or higher-stage lesions, while those that are < 5 cm in length have a greater chance (92 %) of being T1 or T2.
内镜超声检查(EUS)被认为是食管癌T分期最准确的方法。本研究试图确定食管癌的内镜特征,如管腔狭窄的长度和程度,是否能预测EUS的T分期。
本研究纳入了35例新诊断的食管腺癌或鳞状细胞癌患者,这些患者在开始任何治疗前均接受了EUS检查。22例患者在EUS检查前行食管胃十二指肠镜检查(EGD)时前瞻性评估肿瘤长度。然后对这些患者进行径向EUS检查。另外13例患者管腔狭窄严重,导致超声内镜无法完全通过肿瘤。在这13例患者中,未检查食管癌的长度,但记录了超声内镜通过肿瘤的最大推进水平处的T和N分期。
所有13例管腔狭窄患者在超声内镜最大推进水平处至少有T3(n = 12)或T4(n = 1)病变。在22例测量了食管癌长度的患者中,EUS检查为T1或T2病变的13例患者的平均长度为2.6 cm。9例T3期食管癌患者的平均长度为7.1 cm。T1或T2病变的平均长度(2.6 cm)与T3病变的平均长度(7.1 cm)差异有统计学意义(P < 0.001)。采用临床诊断试验方法,以长度≥5 cm作为诊断T3病变的标准时,敏感性为89%,特异性为92%,阳性预测值为89%,阴性预测值为92%。此外,随着食管癌长度增加,淋巴结转移的机会也有增加的趋势。
在食管癌中,癌长度和管腔狭窄程度等内镜特征与EUS的T分期相关。长度≥5 cm或狭窄严重以致内镜无法通过的食管癌更可能是T3期或更高分期的病变,而长度<5 cm的食管癌有更大机会(92%)为T1或T2期。